157 related articles for article (PubMed ID: 23440480)
1. The use of ethanol in paediatric formulations in New Zealand.
Svirskis D; Toh M; Ram S
Eur J Pediatr; 2013 Jul; 172(7):919-26. PubMed ID: 23440480
[TBL] [Abstract][Full Text] [Related]
2. Packaging of medicines for paediatric use: Prescrire's constructive proposals.
Prescrire Int; 2012 Oct; 21(131):249-50. PubMed ID: 23185854
[TBL] [Abstract][Full Text] [Related]
3. Trends in accessibility to medicines for children in New Zealand: 1998-2002.
Chui J; Tordoff J; Kennedy J; Reith D
Br J Clin Pharmacol; 2004 Mar; 57(3):322-7. PubMed ID: 14998428
[TBL] [Abstract][Full Text] [Related]
4. Barriers to administering non-oral formulations in a paediatric population: A semi-structured interview study.
Venables R; Batchelor H; Stirling H; Marriott J
Int J Pharm; 2016 Jan; 497(1-2):12-7. PubMed ID: 26611666
[TBL] [Abstract][Full Text] [Related]
5. Effect of the pediatric exclusivity provision on children's access to medicines.
Grieve J; Tordoff J; Reith D; Norris P
Br J Clin Pharmacol; 2005 Jun; 59(6):730-5. PubMed ID: 15948940
[TBL] [Abstract][Full Text] [Related]
6. European perspectives on pediatric formulations.
Breitkreutz J
Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of ethanol and other potentially harmful excipients in pediatric oral medicines: survey of community pharmacies in a Nigerian City.
Soremekun R; Ogbuefi I; Aderemi-Williams R
BMC Res Notes; 2019 Jul; 12(1):460. PubMed ID: 31349864
[TBL] [Abstract][Full Text] [Related]
8. Changes in availability of paediatric medicines in Australia between 1998 and 2002.
Chui J; Tordoff J; Reith D
Br J Clin Pharmacol; 2005 Jun; 59(6):736-42. PubMed ID: 15948941
[TBL] [Abstract][Full Text] [Related]
9. Dosing information for paediatric patients: are they really "therapeutic orphans"?
Tan E; Cranswick NE; Rayner CR; Chapman CB
Med J Aust; 2003 Aug; 179(4):195-8. PubMed ID: 12914509
[TBL] [Abstract][Full Text] [Related]
10. Extemporaneous (magistral) preparation of oral medicines for children in European hospitals.
Brion F; Nunn AJ; Rieutord A
Acta Paediatr; 2003 Apr; 92(4):486-90. PubMed ID: 12801118
[TBL] [Abstract][Full Text] [Related]
11. Healthcare professional experiences and attitudes on unlicensed/off-label paediatric prescribing and paediatric clinical trials.
Mukattash T; Hawwa AF; Trew K; McElnay JC
Eur J Clin Pharmacol; 2011 May; 67(5):449-61. PubMed ID: 21243345
[TBL] [Abstract][Full Text] [Related]
12. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
13. The availability and age-appropriateness of medicines authorized for children in The Netherlands.
van Riet-Nales DA; de Jager KE; Schobben AF; Egberts TC; Rademaker CM
Br J Clin Pharmacol; 2011 Sep; 72(3):465-73. PubMed ID: 21477143
[TBL] [Abstract][Full Text] [Related]
14. Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.
Venables R; Stirling H; Batchelor H; Marriott J
Int J Clin Pharm; 2015 Dec; 37(6):1057-67. PubMed ID: 26173937
[TBL] [Abstract][Full Text] [Related]
15. Safe, swallowable and palatable paediatric mini-tablet formulations for a WHO model list of essential medicines for children compound - A promising starting point for future PUMA applications.
Freerks L; Sommerfeldt J; Löper PC; Klein S
Eur J Pharm Biopharm; 2020 Nov; 156():11-19. PubMed ID: 32871197
[TBL] [Abstract][Full Text] [Related]
16. Licensing and labelling of drugs in a paediatric oncology ward.
van den Berg H; Tak N
Br J Clin Pharmacol; 2011 Sep; 72(3):474-81. PubMed ID: 21453298
[TBL] [Abstract][Full Text] [Related]
17. Paediatric medicines research in the UK: how to move forward?
Wong I; Sweis D; Cope J; Florence A
Drug Saf; 2003; 26(8):529-37. PubMed ID: 12825967
[TBL] [Abstract][Full Text] [Related]
18. Insufficient access to oral paediatric medicines in Ghana: A descriptive study.
Ankrah DNA; Turkson JT; Boateng EB; Amegavie FTT; Bruce E
BMC Health Serv Res; 2016 Jun; 16():198. PubMed ID: 27317085
[TBL] [Abstract][Full Text] [Related]
19. European Paediatric Formulation Initiative workshop report: Improving the administration of oral liquid medicines in paediatrics using dosing syringes and enteral accessories.
Walsh J; van Riet-Nales D; Hermans E; de Vries R; Hilton G; Blowers P; Salunke S
Eur J Pharm Biopharm; 2020 Jun; 151():91-97. PubMed ID: 32289491
[TBL] [Abstract][Full Text] [Related]
20. Recommended strategies for the oral administration of paediatric medicines with food and drinks in the context of their biopharmaceutical properties: a review.
Martir J; Flanagan T; Mann J; Fotaki N
J Pharm Pharmacol; 2017 Apr; 69(4):384-397. PubMed ID: 27704550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
